These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 17216141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).
    Lee JH, Kim TN, Choi ST, Jang BI, Shin KC, Lee SB, Shim YR.
    Korean J Intern Med; 2007 Mar; 22(1):24-7. PubMed ID: 17427642
    [Abstract] [Full Text] [Related]

  • 6. Conjunctival ulcers in Behçet's disease.
    Zamir E, Bodaghi B, Tugal-Tutkun I, See RF, Charlotte F, Wang RC, Wechsler B, LeHoang P, Anteby I, Rao NA.
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
    Kram MT, May LD, Goodman S, Molinas S.
    Dis Colon Rectum; 2003 Jan; 46(1):118-21. PubMed ID: 12544532
    [Abstract] [Full Text] [Related]

  • 10. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S, Arrigo C, Bocchino L, Morgante L, Sangari D, Castagna I, Bagnato GF.
    BMC Musculoskelet Disord; 2003 Aug 28; 4():19. PubMed ID: 12946278
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
    Olivieri I, Latanza L, Siringo S, Peruz G, Di Iorio V.
    J Rheumatol; 2008 May 28; 35(5):930-2. PubMed ID: 18464316
    [Abstract] [Full Text] [Related]

  • 12. [Behçet's disease with gastrointestinal involvement without evidence for chronic inflammatory bowel disease].
    Philipper M, Schumacher B, Donner A, Neuhaus H.
    Z Gastroenterol; 2004 Aug 28; 42(8):743-7. PubMed ID: 15314728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease.
    Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, Kanai T, Watanabe M, Hibi T.
    Am J Gastroenterol; 2000 Oct 28; 95(10):2848-51. PubMed ID: 11051358
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL.
    Gut; 2001 Nov 28; 49(5):725-8. PubMed ID: 11600479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Behçet's disease in childhood--case reports and review of literature].
    Mori M, Shimizu C, Kuriyama T, Ibe M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1994 Feb 28; 34(1):34-41. PubMed ID: 8146726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.